Table 4.
The clinical relevance analysis of SOCS2-AS1 expression levels in CAD patients.
| Feather | Lower expression (n = 62) | Higher expression (n = 22) | P value |
|---|---|---|---|
| Age (years) | 0.778 | ||
| ≤60 | 15 | 4 | |
| >60 | 47 | 18 | |
|
| |||
| Gender | 0.176 | ||
| Male | 38 | 17 | |
| Female | 24 | 5 | |
|
| |||
| Smoking | 0.904 | ||
| Yes | 12 | 4 | |
| No | 50 | 18 | |
|
| |||
| Hypertension | 0.622 | ||
| Yes | 43 | 14 | |
| No | 19 | 8 | |
|
| |||
| Diabetes | 0.861 | ||
| Yes | 21 | 7 | |
| No | 41 | 15 | |
|
| |||
| Lesion artery number | 0.154 | ||
| Single | 23 | 12 | |
| Multi | 39 | 10 | |
|
| |||
| Severity of artery stenosis | 0.569 | ||
| Severe | 44 | 17 | |
| Slight | 18 | 5 | |
| CRP (mg/L) | 13.87 ± 28.43 | 9.93 ± 15.45 | 0.538 |
| PLT (109/L) | 182.37 ± 50.77 | 141.50 ± 47.39 | 0.001& |
| FIB (g/L) | 2.63 ± 0.92 | 2.43 ± 0.86 | 0.384 |
| INR | 1.04 ± 0.76 | 1.08 ± 0.78 | 0.053 |
| BUN (mmol/L) | 5.95 ± 2.15 | 6.51 ± 2.68 | 0.331 |
| Cr (μmol/L) | 83.22 ± 47.97 | 116.94 ± 159.77 | 0.340 |
| FBG (mmol/L) | 6.44 ± 2.10 | 7.71 ± 4.02 | 0.169 |
| UA (μmol/L) | 350.92 ± 79.42 | 341.82 ± 88.51 | 0.655 |
| TC (mmol/L) | 4.34 ± 1.05 | 4.06 ± 1.02 | 0.275 |
| TG (mmol/L) | 2.13 ± 2.21 | 1.83 ± 1.10 | 0.544 |
| HDL-C (mmol/L) | 1.27 ± 0.30 | 1.25 ± 0.25 | 0.793 |
| LDL-C (mmol/L) | 2.31 ± 0.74 | 2.11 ± 0.74 | 0.292 |
| Lpa (mg/L) | 267.75 ± 228.25 | 179.85 ± 275.71 | 0.146 |
CRP: C-reaction protein; PLT: Platelet; FIB: Fibrinogen; INR: International Normalized Ratio; BUN: Blood Urea Nitrogen; Cr: Creatinine; FBG: Fasting Blood Glucose; UA: Uric Acid; TC: Total Cholesterol; TG: Triglyceride; HDL-C: High Density Lipoprotein-cholesterol; LDL-C: Low Density Lipoprotein-cholesterol; Lpa: Lipoprotein a. &P < 0.01.